Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × fenofibric acid × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Recurrence 1 Medulloblastoma 1 Ependymoma 1

Interventions

pembrolizumab 460 Carboplatin 328 Specimen Handling 325 Magnetic Resonance Spectroscopy 287 Cisplatin 287 Nivolumab 273 Cyclophosphamide 260 Paclitaxel 229 Radiotherapy 217 Biopsy 200 Gemcitabine 191 Bevacizumab 183 Dexamethasone 151 durvalumab 146 Rituximab 144 atezolizumab 137 Capecitabine 137 Oxaliplatin 136 Docetaxel 135 Fluorouracil 133 venetoclax 130 Ipilimumab 121 Drug Therapy 120 Etoposide 119 Doxorubicin 113 Prednisone 111 Lenalidomide 109 Radiosurgery 104 Pemetrexed 98 Leucovorin 98

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01356290 2026-02-23

MEMMAT

Medical University of Vienna

Phase 2 Recruiting

Ependymoma, Medulloblastoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡